Prot # MPI-101-06. Oral Budesonide Suspension (OBS) In Adolescent and Young Adult Subjects (12-25 Years Of Age) With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With An Open-Label Extension